caption
stringlengths 6
2.51k
| molecule
stringlengths 1
747
| properties
sequencelengths 1
86
|
|---|---|---|
The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, barth syndrome, and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, cholesterol translocation that impacts aging and tangier disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Aging",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Tangier disease"
] |
The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts aging, tangier disease, and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts barth syndrome and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC | [
"Proton trap for oxidative phosphorylation",
"Aging",
"Tangier disease",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Diabetic heart disease"
] |
The molecule is a energy storage and a nutrient that impacts cardiovascular disease, metabolic syndrome, obesity, and cancer. The molecule is a energy source and thyroxine treatment, and it impacts pancreatitis. The molecule is a fat storage, a inflammatory, and a membrane stabilizer, and it impacts atherosclerosis. | CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC | [
"Cardiovascular disease",
"Energy storage",
"Metabolic syndrome",
"Obesity",
"Cancer",
"nutrient",
"Energy source",
"Pancreatitis",
"Thyroxine treatment",
"Fat storage",
"inflammatory",
"Membrane stabilizer",
"Atherosclerosis"
] |
The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts barth syndrome, diabetic heart disease, and aging. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease and tangier disease. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCCCC | [
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Diabetic heart disease",
"Apoptosis",
"Aging",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Tangier disease"
] |
The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts diabetic heart disease, tangier disease, and aging. The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, cholesterol translocation that impacts non-alcoholic fatty liver disease and barth syndrome. | CCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)CC | [
"Diabetic heart disease",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Aging",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Cholesterol translocation"
] |
It has an effect on lightening. | CC(=O)[O-].CC(=O)c1cc[n+](C)c(C(C)=O)c1 | [
"lightening"
] |
The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts diabetic heart disease, barth syndrome, and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, cholesterol translocation that impacts tangier disease and aging. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\CCCCCCCC | [
"Diabetic heart disease",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Aging",
"Cholesterol translocation"
] |
The molecule is a stabilizing cytochrome oxidase, apoptosis, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts tangier disease, aging, and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCC/C=C\C/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC | [
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Aging",
"Barth syndrome",
"Cholesterol translocation"
] |
The molecule is a hdm2 inhibitor and is cancer treatment. | Cc1cccc(-c2cc3nc(Cl)nc(NC(C)C4CCC4)c3[nH]2)c1 | [
"cancer treatment",
"hdm2 inhibitor"
] |
The molecule is apricot, fruity, ethereal, and banana. The molecule is a flavoring agent, musty, sweet, and oily. | N=C(O)C(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)c1ccccc1 | [
"apricot",
"fruity",
"ethereal",
"banana",
"musty",
"sweet",
"Flavoring agent",
"oily"
] |
Ethylene dichloride decomposes slowly becoming acidic and darkening in color. The molecule has both a Sweet taste and a Pleasant odor. | ClCCCl | [
"Decomposition_evaluation",
"taste_evaluation",
"Odor_evaluation"
] |
The molecule is a energy source, inflammatory, membrane stabilizer that impacts metabolic syndrome, obesity, and atherosclerosis. The molecule is a energy storage that affects cancer by impacting pancreatitis. The molecule is a nutrient, a fat storage, and a thyroxine treatment, and it impacts cardiovascular disease. | CC(C)CCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCC(C)C | [
"Energy source",
"inflammatory",
"Metabolic syndrome",
"Membrane stabilizer",
"Obesity",
"Atherosclerosis",
"Pancreatitis",
"Cancer",
"Energy storage",
"nutrient",
"Cardiovascular disease",
"Fat storage",
"Thyroxine treatment"
] |
The molecule is photoresist. | OCC1C2C=CC(C2)C1C(F)(F)F | [
"photoresist"
] |
The molecule is a apoptosis, cholesterol translocation, proton trap for oxidative phosphorylation that impacts barth syndrome and diabetic heart disease. The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts aging, tangier disease, and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCC | [
"Apoptosis",
"Barth syndrome",
"Cholesterol translocation",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Aging",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease"
] |
The molecule is cancer treatment and anti apoptotic. | CCCCN(CCCC)C(=O)c1cn(CCc2ccccc2)c(-c2ccc(C(=O)O)cc2C(=O)N2Cc3ccccc3CC2CO)n1 | [
"cancer treatment",
"anti apoptotic"
] |
The molecule is a btk inhibitor. | COCCNC(=O)c1ccc(C(=O)c2c[nH]c3ncnc(NC4CCC(CO)OC4)c23)c(Cl)c1 | [
"btk inhibitor"
] |
The molecule is a thyroxine treatment, energy storage, fat storage, inflammatory that impacts atherosclerosis and obesity. The molecule is a energy source and membrane stabilizer, and it impacts metabolic syndrome. The molecule is a nutrient that affects cancer by impacting both cardiovascular disease and pancreatitis. | CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC | [
"Thyroxine treatment",
"Atherosclerosis",
"Energy storage",
"Fat storage",
"Obesity",
"inflammatory",
"Metabolic syndrome",
"Energy source",
"Membrane stabilizer",
"Cancer",
"Cardiovascular disease",
"nutrient",
"Pancreatitis"
] |
The molecule is a acc inhibitor and a cancer treatment, belonging to the metabolic syndrome treatment class of molecules. | CC(COc1cnc(-c2ccc(Br)cn2)o1)NC(=O)O | [
"acc inhibitor",
"metabolic syndrome treatment",
"cancer treatment"
] |
The molecule is a nutrient that affects breast cancer by impacting cervical cancer, atherosclerosis, and ulcerative colitis. | CCCCCCCCCCCCCCCCC=COC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=C\C[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCCCC | [
"Breast cancer",
"Cervical cancer",
"nutrient",
"Atherosclerosis",
"Ulcerative colitis"
] |
The molecule is a membrane stabilizer and fat storage, belonging to the thyroxine treatment class of molecules, with effects on cancer and impacts on both obesity and metabolic syndrome. The molecule is a inflammatory, a energy source, and a energy storage. The molecule is a nutrient that impacts atherosclerosis, pancreatitis, and cardiovascular disease. | CCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCC(C)CC | [
"Obesity",
"Thyroxine treatment",
"Cancer",
"Metabolic syndrome",
"Membrane stabilizer",
"Fat storage",
"inflammatory",
"Energy source",
"Energy storage",
"Atherosclerosis",
"Pancreatitis",
"nutrient",
"Cardiovascular disease"
] |
The molecule is a cholesterol translocation that impacts diabetic heart disease, tangier disease, aging, and barth syndrome. The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCC | [
"Diabetic heart disease",
"Tangier disease",
"Aging",
"Cholesterol translocation",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase"
] |
It impacts cancer treatment. | Cc1[nH]nc2ccc(-c3cncc(NC(CO)c4ccccc4)c3)cc12 | [
"cancer treatment"
] |
The molecule is a modulate and belongs to the cb1 antagonist class of molecules. | CCCCCCC(CN(C(N)=O)c1ccc(C)cc1)c1ccccc1 | [
"modulate",
"cb1 antagonist"
] |
The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts tangier disease, diabetic heart disease, and aging. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis that impacts non-alcoholic fatty liver disease and barth syndrome. | CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCC | [
"Tangier disease",
"Diabetic heart disease",
"Aging",
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Barth syndrome"
] |
The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, cholesterol translocation that impacts aging. The molecule is a apoptosis that impacts tangier disease, non-alcoholic fatty liver disease, diabetic heart disease, and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC | [
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Aging",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Diabetic heart disease",
"Barth syndrome"
] |
When heated to decomposition it emits toxic vapros of hydrogen chloride. | CC(Cl)=CCCl | [
"Decomposition_evaluation"
] |
The molecule is a tachykinin antagonist. | CC(=O)N(C)C(COCc1cc(C)cc(C)c1)C(c1ccccc1)c1ccccc1 | [
"tachykinin antagonist"
] |
The molecule is a glycogen phosphorylase inhibitor and belongs to the metabolic disorder treatment class of molecules, impacting diabetes treatment. | CNC(=O)N1CCc2c(N)cccc21 | [
"metabolic disorder treatment",
"diabetes treatment",
"glycogen phosphorylase inhibitor"
] |
The molecule is a nutrient that impacts both metabolic syndrome and atherosclerosis. The molecule is a fat storage and a thyroxine treatment, impacting both cardiovascular disease and pancreatitis. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@@H](COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC | [
"Metabolic syndrome",
"Atherosclerosis",
"nutrient",
"Cardiovascular disease",
"Pancreatitis",
"Fat storage",
"Thyroxine treatment"
] |
The molecule is a apoptosis and a cholesterol translocation that impacts tangier disease, barth syndrome, and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts aging and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Tangier disease",
"Apoptosis",
"Barth syndrome",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Aging",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure"
] |
The molecule is a energy source that impacts diabetes mellitus type 2, breast cancer, and cardiovascular disease. It impacts celiac disease, heart failure, renal cell carcinoma, and inflammatory bowel disease. | C[N+](C)(C)CC(CC(=O)[O-])OC(=O)CCCCO | [
"Diabetes mellitus type 2",
"Breast cancer",
"Cardiovascular disease",
"Energy source",
"Celiac disease",
"Heart failure",
"Renal cell carcinoma",
"Inflammatory bowel disease"
] |
It has an effect on stomach cancer, and impacts diabetes mellitus, breast cancer, and parkinson's disease. It has an effect on colorectal cancer, and impacts alzheimer's disease, cardiovascular disease, and seizure. | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C=C\[C@H](O)CCCCC)COP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O | [
"Diabetes mellitus",
"Stomach cancer",
"Breast cancer",
"Parkinson's disease",
"Alzheimer's Disease",
"Colorectal cancer",
"Cardiovascular disease",
"Seizure"
] |
The molecule is a nutrient that affects both cervical cancer and breast cancer, and also impacts ulcerative colitis and atherosclerosis. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Ulcerative colitis",
"nutrient",
"Cervical cancer",
"Atherosclerosis",
"Breast cancer"
] |
The molecule is a apoptosis and a cholesterol translocation that impacts barth syndrome, aging, and tangier disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts diabetic heart disease and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC)OC(=O)CCCCCCCCCCC(C)CC | [
"Apoptosis",
"Cholesterol translocation",
"Barth syndrome",
"Aging",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease"
] |
The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, apoptosis that impacts tangier disease and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, diabetic heart disease, and aging. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC | [
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Tangier disease",
"Barth syndrome",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Aging"
] |
The molecule is a inflammatory treatment member of the anti inflammatory class. | COc1ccc(C(=O)c2oc3ccccc3c2CSCCC(=O)O)cc1C(=O)NS(=O)(=O)c1ccccc1C | [
"inflammatory treatment",
"anti inflammatory"
] |
The molecule is a nutrient. | O=C(/C=C/c1ccc(O)c(O)c1)OCC1OC(Oc2cc3c(OC4OC(CO)C(O)C(O)C4O)cc(O)cc3[o+]c2-c2ccc(O)c(O)c2)C(O)C(O)C1O | [
"nutrient"
] |
The molecule is a anti biotic and belongs to the anti microbial class of molecules, with the characteristic of being anti bacterial. | CSC1C(C(C)O[Si](C)(C)C(C)(C)C)C(=O)N1C(O)C(=O)OCc1ccc([N+](=O)[O-])cc1 | [
"anti biotic",
"anti microbial",
"anti bacterial"
] |
The molecule is a nutrient that affects cervical cancer by impacting atherosclerosis, ulcerative colitis, and breast cancer. | CC/C=C\C/C=C\C/C=C\C/C=C\C=C\C(O)CCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)O/C=C/CCCCCCCCCCCCCCCC | [
"Cervical cancer",
"Atherosclerosis",
"Ulcerative colitis",
"Breast cancer",
"nutrient"
] |
The molecule is a liquid crystal. | COc1cc(C=C(CCc2ccc(N)cc2N)C(=O)O)ccc1OC(=O)c1ccc(OCCCCC(F)(F)F)cc1 | [
"liquid crystal"
] |
The molecule is a nutrient. | C=C1C=CC(C(C)CC(O)C=C(C)C)CC1 | [
"nutrient"
] |
It belongs to the chemokine receptor modulator class of molecules. | COc1ccc(NC(C)=O)c(OCC(N)CN2CCC3(CC2)Cc2ccccc2O3)c1 | [
"chemokine receptor modulator"
] |
The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, apoptosis that impacts diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts barth syndrome, tangier disease, and aging. | CCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Diabetic heart disease",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Tangier disease",
"Aging",
"Stabilizing mitochondrial structure"
] |
The molecule is a diabetes treatment. | CC(=O)c1cc(Oc2ccc(S(C)(=O)=O)cc2)cc(Oc2ncccn2)c1 | [
"diabetes treatment"
] |
The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts aging, barth syndrome, and tangier disease. The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, cholesterol translocation that impacts non-alcoholic fatty liver disease and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCC(C)C | [
"Aging",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Barth syndrome",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Cholesterol translocation"
] |
The molecule is a nutrient. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC/C=C/C=C\C(O)C/C=C\C/C=C\CCCCC | [
"nutrient"
] |
The molecule is a nutrient, energy storage, thyroxine treatment that impacts obesity, cardiovascular disease, and atherosclerosis. The molecule is a inflammatory and energy source, and it impacts pancreatitis. The molecule is a fat storage and a membrane stabilizer, impacting both cancer and metabolic syndrome. | CCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCCCC(C)C | [
"Obesity",
"Cardiovascular disease",
"nutrient",
"Energy storage",
"Thyroxine treatment",
"Atherosclerosis",
"inflammatory",
"Pancreatitis",
"Energy source",
"Cancer",
"Fat storage",
"Metabolic syndrome",
"Membrane stabilizer"
] |
The molecule is a cholesterol translocation, stabilizing mitochondrial structure, apoptosis, stabilizing cytochrome oxidase that impacts diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, aging, tangier disease, and barth syndrome. | CC/C=C\C/C=C\C/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC | [
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation",
"Aging",
"Tangier disease",
"Barth syndrome"
] |
The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts barth syndrome, non-alcoholic fatty liver disease, and aging. The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts diabetic heart disease and tangier disease. | CCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC(C)C | [
"Barth syndrome",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Aging",
"Diabetic heart disease",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Tangier disease"
] |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, proton trap for oxidative phosphorylation that impacts tangier disease and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts non-alcoholic fatty liver disease, aging, and barth syndrome. | CCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCCCCCC | [
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Tangier disease",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Aging",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Apoptosis"
] |
The molecule is a cholesterol translocation that impacts aging, diabetic heart disease, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts tangier disease. | CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCC | [
"Aging",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Cholesterol translocation",
"Apoptosis",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure"
] |
The molecule is a cholesterol translocation and a apoptosis that impacts non-alcoholic fatty liver disease, aging, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts tangier disease and barth syndrome. | CCCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Apoptosis",
"Aging",
"Diabetic heart disease",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure"
] |
The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts barth syndrome, aging, and non-alcoholic fatty liver disease. The molecule is a apoptosis, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts diabetic heart disease and tangier disease. | CCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C | [
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Aging",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, tangier disease, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, apoptosis, proton trap for oxidative phosphorylation that impacts aging and barth syndrome. | CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Diabetic heart disease",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Aging",
"Proton trap for oxidative phosphorylation",
"Barth syndrome"
] |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, stabilizing cytochrome oxidase, apoptosis that impacts non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation that impacts barth syndrome, tangier disease, diabetic heart disease, and aging. | CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCC(C)C | [
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Barth syndrome",
"Tangier disease",
"Diabetic heart disease",
"Aging"
] |
The molecule is a membrane stabilizer, energy source, and emulsifier that has an effect on prostate cancer and impacts both colorectal cancer and cardiovascular disease. The molecule is a surfactant that affects testicular cancer by impacting atherosclerosis. The molecule is a hormone, a signalling molecule, and a energy storage, and it impacts breast cancer. | CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CCC3C4CCC([C@H](C)CCCC(C)C)[C@@]4(C)CCC32)C1 | [
"Membrane stabilizer",
"Colorectal cancer",
"Cardiovascular disease",
"Energy source",
"Emulsifier",
"Prostate cancer",
"surfactant",
"Testicular cancer",
"Atherosclerosis",
"hormone",
"Breast cancer",
"signalling molecule",
"Energy storage"
] |
The molecule is odorless. | CCCCC/C=C\C=C\C=C/CCCCCCC(=O)O | [
"odorless"
] |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, stabilizing cytochrome oxidase that impacts tangier disease and aging. The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts diabetic heart disease, barth syndrome, and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC | [
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Tangier disease",
"Aging",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Barth syndrome",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease"
] |
The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts tangier disease and diabetic heart disease. The molecule is a cholesterol translocation and a apoptosis that impacts barth syndrome, non-alcoholic fatty liver disease, and aging. | CCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC | [
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Aging",
"Apoptosis"
] |
The molecule is a energy source, surfactant, emulsifier, membrane stabilizer, nutrient, energy storage. | Cc1ncc(C[n+]2csc(CCOP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@@H](O)[C@H]3O)c2C)c(N)n1 | [
"Energy source",
"surfactant",
"Emulsifier",
"Membrane stabilizer",
"nutrient",
"Energy storage"
] |
The molecule is a inflammatory, energy source, membrane stabilizer, energy storage that impacts pancreatitis and metabolic syndrome. It has an effect on cancer, impacting both obesity and cardiovascular disease. The molecule is a nutrient and a fat storage, it impacts atherosclerosis, and is thyroxine treatment. | CCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC(C)CC)COC(=O)CCCCCCCCCCC(C)C | [
"Pancreatitis",
"inflammatory",
"Metabolic syndrome",
"Energy source",
"Membrane stabilizer",
"Energy storage",
"Obesity",
"Cancer",
"Cardiovascular disease",
"Thyroxine treatment",
"nutrient",
"Fat storage",
"Atherosclerosis"
] |
The molecule is a nutrient that impacts both pancreatitis and cardiovascular disease. The molecule is a fat storage that impacts metabolic syndrome, atherosclerosis, and thyroxine treatment. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCC/C=C\C/C=C\C/C=C\CCCCC | [
"nutrient",
"Pancreatitis",
"Cardiovascular disease",
"Metabolic syndrome",
"Fat storage",
"Atherosclerosis",
"Thyroxine treatment"
] |
The molecule is a member of the thyroxine treatment class and affects both pancreatitis and metabolic syndrome. The molecule is a nutrient and a fat storage, impacting both atherosclerosis and cardiovascular disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCC/C=C\CCCCCC)OC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Pancreatitis",
"Metabolic syndrome",
"Thyroxine treatment",
"nutrient",
"Fat storage",
"Atherosclerosis",
"Cardiovascular disease"
] |
The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts aging, diabetic heart disease, and non-alcoholic fatty liver disease. The molecule is a apoptosis, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts tangier disease and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Aging",
"Cholesterol translocation",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a anti cancer member of the cancer treatment class. | C=C1C=C(C)c2ccc3oc(C(=O)c4cccc(OCCN5CCC(Cc6ccccc6)CC5)c4)c(-c4ccccc4)c3c2O1 | [
"cancer treatment",
"anti cancer"
] |
The molecule is a fat storage, a inflammatory, and a membrane stabilizer that impacts both cardiovascular disease and atherosclerosis, and is thyroxine treatment. The molecule is a energy storage that impacts both pancreatitis and obesity. The molecule is a energy source and a nutrient, with effects on cancer and impacts on metabolic syndrome. | CCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCC(C)C | [
"Cardiovascular disease",
"Fat storage",
"inflammatory",
"Thyroxine treatment",
"Atherosclerosis",
"Membrane stabilizer",
"Pancreatitis",
"Obesity",
"Energy storage",
"Metabolic syndrome",
"Energy source",
"nutrient",
"Cancer"
] |
The molecule is a nutrient, fat storage, energy source that impacts metabolic syndrome, cancer, and obesity. The molecule is a inflammatory and membrane stabilizer, and it impacts cardiovascular disease. The molecule is a energy storage and a thyroxine treatment, impacting both atherosclerosis and pancreatitis. | CCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)C | [
"nutrient",
"Metabolic syndrome",
"Fat storage",
"Cancer",
"Obesity",
"Energy source",
"Cardiovascular disease",
"inflammatory",
"Membrane stabilizer",
"Energy storage",
"Thyroxine treatment",
"Atherosclerosis",
"Pancreatitis"
] |
The molecule is a apoptosis, cholesterol translocation, stabilizing mitochondrial structure that impacts tangier disease and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation that impacts diabetic heart disease, aging, and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Apoptosis",
"Cholesterol translocation",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Aging",
"Barth syndrome",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a fat storage and nutrient, and it impacts cardiovascular disease. The molecule is thyroxine treatment and impacts atherosclerosis, pancreatitis, and metabolic syndrome. | CCCC/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCC)OC(=O)CCCCCCC/C=C\CCCC | [
"Fat storage",
"nutrient",
"Cardiovascular disease",
"Thyroxine treatment",
"Atherosclerosis",
"Pancreatitis",
"Metabolic syndrome"
] |
The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts barth syndrome, tangier disease, and aging. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, apoptosis that impacts non-alcoholic fatty liver disease and diabetic heart disease. | CCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCC | [
"Proton trap for oxidative phosphorylation",
"Barth syndrome",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Aging",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease"
] |
The molecule is cancer treatment. | C=C(F)C(=O)N1CC(C)N(C)CC1CC#N | [
"cancer treatment"
] |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, apoptosis, proton trap for oxidative phosphorylation that impacts barth syndrome. The molecule is a stabilizing cytochrome oxidase that impacts aging, tangier disease, non-alcoholic fatty liver disease, and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Apoptosis",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Aging",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase"
] |
The molecule is a diabetes treatment member of the obesity treatment class. | COC(=O)C(C)CCc1cnc(CCc2ccc(-c3ccccc3C(=O)O)cc2)[nH]1 | [
"obesity treatment",
"diabetes treatment"
] |
The molecule is a anti oxidant and belongs to both the anti viral and anti microbial classes of molecules. | CC1=CC(=O)N(Cc2ccccc2)C(=O)C1 | [
"anti oxidant",
"anti viral",
"anti microbial"
] |
The molecule is a stabilizing cytochrome oxidase, a energy storage, and a food additive, and it impacts non-alcoholic fatty liver disease. The molecule is a surfactant, membrane stabilizer, stabilizing mitochondrial structure, nutritional supplement that impacts barth syndrome. The molecule is a proton trap for oxidative phosphorylation, a cholesterol translocation, a emulsifier, and smooth. The molecule is a apoptosis and a energy source that impacts diabetic heart disease, tangier disease, and aging. | CCC(C)CCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Stabilizing cytochrome oxidase",
"Energy storage",
"food additive",
"Non-alcoholic fatty liver disease",
"surfactant",
"Membrane stabilizer",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Nutritional supplement",
"Smooth",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Emulsifier",
"Diabetic heart disease",
"Apoptosis",
"Energy source",
"Tangier disease",
"Aging"
] |
The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts diabetic heart disease, aging, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, apoptosis that impacts barth syndrome and tangier disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC | [
"Cholesterol translocation",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Aging",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Apoptosis",
"Tangier disease"
] |
The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts diabetic heart disease, barth syndrome, and tangier disease. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease and aging. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCC | [
"Diabetic heart disease",
"Apoptosis",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Aging",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a inflammatory, fat storage, energy source that impacts metabolic syndrome, atherosclerosis, and cardiovascular disease. The molecule is a nutrient that affects cancer by impacting obesity. The molecule is a membrane stabilizer, a thyroxine treatment, and a energy storage, and it impacts pancreatitis. | CCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC(C)C | [
"inflammatory",
"Fat storage",
"Energy source",
"Metabolic syndrome",
"Atherosclerosis",
"Cardiovascular disease",
"Obesity",
"Cancer",
"nutrient",
"Membrane stabilizer",
"Pancreatitis",
"Thyroxine treatment",
"Energy storage"
] |
The molecule is a anti tumour member of the cancer treatment class. | CC1Cc2c([nH]c3ccccc23)C(c2c(F)cc(OCCOCCOCC(=O)OC(C)(C)C)cc2F)N1CC(C)(C)F | [
"anti tumour",
"cancer treatment"
] |
The molecule is both a cgrp antagonist and a migraine treatment. | CCCCCCCCC(=O)OCn1ncc2cc(CC(NC(=O)N3CCC(c4cc5ccccc5[nH]c4=O)CC3)C(=O)N3CCN(C4CCN(C)CC4)CC3)cc(C)c21 | [
"cgrp antagonist",
"migraine treatment"
] |
The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing mitochondrial structure that impacts aging and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCC(C)C | [
"Aging",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation"
] |
The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, barth syndrome, and tangier disease. The molecule is a stabilizing mitochondrial structure, apoptosis, proton trap for oxidative phosphorylation that impacts diabetic heart disease and aging. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC | [
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Aging",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a nutrient that affects both cervical cancer and breast cancer, and also impacts ulcerative colitis and atherosclerosis. | CC/C=C\C(O)C/C=C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | [
"Cervical cancer",
"Ulcerative colitis",
"Atherosclerosis",
"nutrient",
"Breast cancer"
] |
The molecule is a apoptosis, cholesterol translocation, proton trap for oxidative phosphorylation that impacts tangier disease and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, aging, and barth syndrome. | CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCC(C)C | [
"Tangier disease",
"Apoptosis",
"Cholesterol translocation",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Aging",
"Barth syndrome"
] |
The molecule is a energy source, inflammatory, energy storage that impacts obesity, cardiovascular disease, and cancer. The molecule is a nutrient and membrane stabilizer, and it impacts pancreatitis. The molecule is a fat storage that impacts atherosclerosis, metabolic syndrome, and thyroxine treatment. | CCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCC | [
"Obesity",
"Energy source",
"Cardiovascular disease",
"inflammatory",
"Cancer",
"Energy storage",
"nutrient",
"Membrane stabilizer",
"Pancreatitis",
"Atherosclerosis",
"Fat storage",
"Metabolic syndrome",
"Thyroxine treatment"
] |
The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts aging and barth syndrome. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts tangier disease, non-alcoholic fatty liver disease, and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC | [
"Apoptosis",
"Aging",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Cholesterol translocation",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Diabetic heart disease"
] |
The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts aging, barth syndrome, and tangier disease. | CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC(C)CC | [
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Aging",
"Barth syndrome",
"Tangier disease"
] |
The molecule is a anti viral, ns5a inhibitor, hcv inhibitor, hepatitis c treatment. | CC(C)(C)OC(=O)N1CCOCC1C(=O)N(CC=O)c1ccc(Br)cc1 | [
"anti viral",
"ns5a inhibitor",
"hcv inhibitor",
"hepatitis c treatment"
] |
The molecule is a nutrient. | COc1cc(-c2[o+]c3cc(O)cc(O)c3cc2O[C@@H]2O[C@H](CO)[C@H](O)[C@H]2O)ccc1O | [
"nutrient"
] |
The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts aging, diabetic heart disease, and tangier disease. The molecule is a stabilizing cytochrome oxidase, apoptosis, stabilizing mitochondrial structure that impacts barth syndrome and non-alcoholic fatty liver disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Aging",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Tangier disease",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease"
] |
The molecule is a energy storage, nutrient, surfactant, green, and fruity. The molecule is a energy source, emulsifier, membrane stabilizer, flavoring agent, and grape. | O=C(O)c1nn(-c2ccc(S(=O)(=O)O)cc2)c(O)c1/N=N/c1ccc(S(=O)(=O)O)cc1 | [
"green",
"fruity",
"Energy storage",
"nutrient",
"surfactant",
"Energy source",
"Emulsifier",
"Membrane stabilizer",
"grape",
"Flavoring agent"
] |
The molecule is a potassium channel inhibitor. | CNCOc1cc(-c2ccccc2)[nH]n1 | [
"potassium channel inhibitor"
] |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, proton trap for oxidative phosphorylation that impacts aging and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts tangier disease, non-alcoholic fatty liver disease, and barth syndrome. | CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC | [
"Stabilizing mitochondrial structure",
"Aging",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Apoptosis"
] |
The molecule is a nutrient that affects breast cancer by impacting cervical cancer, ulcerative colitis, and atherosclerosis. | CCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)([O-])OCC[N+](C)(C)C | [
"Cervical cancer",
"Breast cancer",
"Ulcerative colitis",
"nutrient",
"Atherosclerosis"
] |
The molecule is both a cancer treatment and a kinase inhibitor. | CCc1ncnc(N2CCC3(CCN(C(C)=O)CC3)CC2)c1-c1ccc(N)nc1 | [
"cancer treatment",
"kinase inhibitor"
] |
The molecule is a stabilizing cytochrome oxidase that impacts barth syndrome, tangier disease, diabetic heart disease, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, apoptosis, proton trap for oxidative phosphorylation, cholesterol translocation that impacts aging. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Barth syndrome",
"Tangier disease",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Aging",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation"
] |
It impacts prostate cancer treatment. | CC(CCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)NC(=O)CCc1ccc(I)cc1 | [
"prostate cancer treatment"
] |
The molecule is a fat storage and energy source, belonging to the thyroxine treatment class of molecules, with effects on cancer and impacts on both metabolic syndrome and obesity. The molecule is a membrane stabilizer that impacts both pancreatitis and atherosclerosis. The molecule is a energy storage, a inflammatory, and a nutrient, and it impacts cardiovascular disease. | CCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCC(C)C | [
"Fat storage",
"Metabolic syndrome",
"Obesity",
"Cancer",
"Thyroxine treatment",
"Energy source",
"Pancreatitis",
"Atherosclerosis",
"Membrane stabilizer",
"Energy storage",
"Cardiovascular disease",
"inflammatory",
"nutrient"
] |
The molecule is a thyroxine treatment that impacts both cardiovascular disease and pancreatitis. The molecule is a fat storage and a nutrient, impacting both atherosclerosis and metabolic syndrome. | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Thyroxine treatment",
"Cardiovascular disease",
"Pancreatitis",
"Atherosclerosis",
"Metabolic syndrome",
"Fat storage",
"nutrient"
] |
It impacts cancer treatment. | CCC(C)(C)Cc1c(C=O)cc(-c2nc(-c3ccc(Cl)cc3)cs2)c(=O)n1-c1c(C)n[nH]c1C | [
"cancer treatment"
] |
Subsets and Splits